NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
出版年份 2015 全文链接
标题
NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
作者
关键词
-
出版物
OncoImmunology
Volume 5, Issue 4, Pages e1093276
出版商
Informa UK Limited
发表日期
2015-12-11
DOI
10.1080/2162402x.2015.1093276
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
- (2015) W. Deng et al. SCIENCE
- Effect of NKG2D ligand expression on host immune responses
- (2015) Marine Champsaur et al. IMMUNOLOGICAL REVIEWS
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
- (2013) Guranda Chitadze et al. INTERNATIONAL JOURNAL OF CANCER
- Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation
- (2013) Wai-Hang Leung et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human V 2V 2 T Cells
- (2013) H. Wang et al. JOURNAL OF IMMUNOLOGY
- Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
- (2013) Stefano Vavassori et al. NATURE IMMUNOLOGY
- A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells
- (2013) Fabian Wolpert et al. NEURO-ONCOLOGY
- ADAM17, shedding, TACE as therapeutic targets
- (2013) Stefan Rose-John PHARMACOLOGICAL RESEARCH
- Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
- (2013) Lawrence S. Lamb et al. PLoS One
- Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
- (2013) G. Chitadze et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- New prospects on the NKG2D/NKG2DL system for oncology
- (2013) Evelyn Ullrich et al. OncoImmunology
- Adoptive Cell Therapies for Glioblastoma
- (2013) Kevin Bielamowicz et al. Frontiers in Oncology
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset
- (2012) C. Harly et al. BLOOD
- Exosome removal as a therapeutic adjuvant in cancer
- (2012) Annette M Marleau et al. Journal of Translational Medicine
- Current concepts and management of glioblastoma
- (2011) Matthias Preusser et al. ANNALS OF NEUROLOGY
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding
- (2011) Sonia Agüera-González et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells
- (2011) L. Fernandez-Messina et al. JOURNAL OF CELL SCIENCE
- Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer
- (2011) Baocheng Huang et al. JOURNAL OF IMMUNOTHERAPY
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
- (2011) C. A. Crane et al. NEURO-ONCOLOGY
- Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
- (2011) C. E. Fadul et al. NEURO-ONCOLOGY
- Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells
- (2011) Malin Hedlund et al. PLoS One
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
- (2010) O. Ashiru et al. CANCER RESEARCH
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands
- (2010) Lola Fernández-Messina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease
- (2010) Daniela F. Angelini et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme
- (2010) Nichole L. Bryant et al. JOURNAL OF NEURO-ONCOLOGY
- Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma
- (2010) Nam ONCOLOGY REPORTS
- Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human T Cells
- (2009) H. Shojaei et al. CANCER RESEARCH
- Role of ADAMs in Cancer Formation and Progression
- (2009) M. J. Duffy et al. CLINICAL CANCER RESEARCH
- DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells
- (2009) Olivier Toutirais et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- An integrated view of the regulation of NKG2D ligands
- (2009) Noam Stern-Ginossar et al. IMMUNOLOGY
- Brief Residence at the Plasma Membrane of the MHC Class I-Related Chain B Is Due to Clathrin-Mediated Cholesterol-Dependent Endocytosis and Shedding
- (2009) S. Aguera-Gonzalez et al. JOURNAL OF IMMUNOLOGY
- Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
- (2009) Nichole L. Bryant et al. NEURO-ONCOLOGY
- Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
- (2008) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor
- (2008) L. Witters et al. CANCER RESEARCH
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
- Soluble NKG2D ligands: prevalence, release, and functional impact
- (2008) Helmut Rainer Salih Frontiers in Bioscience-Landmark
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now